EMUC 2024: Optimising strategies in mHSPC and mCRPC

SIOG 2024: Updates in haematology

One-year mortality in older adults with breast cancer: prediction using different geriatric tools

Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients

Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting

Understanding the remaining unmet needs in a post ASCT NDMM setting

Approaches to risk stratification in high risk myeloma

Use of bispecifics and CAR T cells in South America

Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM

Revolutionising myeloma treatment through immune profiling

Treating relapsed multiple myeloma outside of use of T-cell redirected therapies

Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan